Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acadia, ADC, Astellas, Beigene, Crispr, Disc, Editas, Faron, Genmab, Gritstone, Immunogen, Keros, Nuvox, Roche, Ryvu, Servier, Vertex, Vor, Wugen.